Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect

Mikhail Brovko,1 Lidia Kozlovskaya,1 Andrey Pulin,1,2 Sergey Moiseev,1 Victoria Sholomova,1 Dmitry Shchekochikhin,1 Daria Gognieva,1 Ludmila Milovanova,1 Victor Fomin1 1Sechenov First Moscow State Medical University, Moscow, Russia; 2Laboratory for Cell Technologies and Developmental Pathology, Fede...

Full description

Bibliographic Details
Main Authors: Brovko M, Kozlovskaya L, Pulin A, Moiseev S, Sholomova V, Shchekochikhin D, Gognieva D, Milovanova L, Fomin V
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:International Journal of Nephrology and Renovascular Disease
Subjects:
Online Access:https://www.dovepress.com/low-aquaporin-2-excretion-in-the-nephrotic-syndrome-an-escape-from-the-peer-reviewed-article-IJNRD
_version_ 1811336734315642880
author Brovko M
Kozlovskaya L
Pulin A
Moiseev S
Sholomova V
Shchekochikhin D
Gognieva D
Milovanova L
Fomin V
author_facet Brovko M
Kozlovskaya L
Pulin A
Moiseev S
Sholomova V
Shchekochikhin D
Gognieva D
Milovanova L
Fomin V
author_sort Brovko M
collection DOAJ
description Mikhail Brovko,1 Lidia Kozlovskaya,1 Andrey Pulin,1,2 Sergey Moiseev,1 Victoria Sholomova,1 Dmitry Shchekochikhin,1 Daria Gognieva,1 Ludmila Milovanova,1 Victor Fomin1 1Sechenov First Moscow State Medical University, Moscow, Russia; 2Laboratory for Cell Technologies and Developmental Pathology, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology,” Moscow, Russia Purpose: Experimental studies suggest that the nephrotic syndrome is associated with “vasopressin escape”, characterized by low aquaporin-2 (AQP2) expression in the collecting duct despite high vasopressin secretion. We investigated this phenomenon in patients with the nephrotic syndrome. Patients and methods: We recruited 47 patients with proteinuric kidney disease who were distributed into the following four groups: 1) nephrotic syndrome with kidney dysfunction (n=10); 2) nephrotic syndrome with normal kidney function (n=16); 3) partial remission of nephrotic syndrome (n=10); and 4) minimal proteinuria (n=11). Nine healthy volunteers comprised a control group. Serum copeptin level (as a marker of vasopressin secretion) and urinary AQP2 were measured using ELISA. Results: Nephrotic syndrome was associated with a significant increase in serum copeptin levels compared with those in the other groups (all P<0.05). In patients with nephrotic syndrome and a partial remission of nephrotic syndrome combined, there was more than a ten-fold decrease in the median urinary AQP2 excretion (0.03 ng/mL) compared with healthy volunteers (0.41 ng/mL; P<0.001) and more than a five-fold decrease compared with patients with minimal proteinuria (0.21 ng/mL; P<0.05). Unlike copeptin levels, the median urinary AQP2 excretion in patients with minimal proteinuria also decreased but less significantly than in those with nephrotic syndrome. There was a negative correlation between the urinary AQP2 excretion and daily proteinuria (R=−0.41; P=0.005). Conclusion: Our clinical study was the first to demonstrate low AQP2 excretion in nephrotic syndrome that may indicate an escape from the vasopressin regulating effect. Keywords: nephrotic syndrome, aquaporin-2, copeptin, vasopressin escape
first_indexed 2024-04-13T17:43:53Z
format Article
id doaj.art-05cf4d15685d45198fc416509b4516cb
institution Directory Open Access Journal
issn 1178-7058
language English
last_indexed 2024-04-13T17:43:53Z
publishDate 2018-10-01
publisher Dove Medical Press
record_format Article
series International Journal of Nephrology and Renovascular Disease
spelling doaj.art-05cf4d15685d45198fc416509b4516cb2022-12-22T02:37:03ZengDove Medical PressInternational Journal of Nephrology and Renovascular Disease1178-70582018-10-01Volume 1127127741575Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effectBrovko MKozlovskaya LPulin AMoiseev SSholomova VShchekochikhin DGognieva DMilovanova LFomin VMikhail Brovko,1 Lidia Kozlovskaya,1 Andrey Pulin,1,2 Sergey Moiseev,1 Victoria Sholomova,1 Dmitry Shchekochikhin,1 Daria Gognieva,1 Ludmila Milovanova,1 Victor Fomin1 1Sechenov First Moscow State Medical University, Moscow, Russia; 2Laboratory for Cell Technologies and Developmental Pathology, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology,” Moscow, Russia Purpose: Experimental studies suggest that the nephrotic syndrome is associated with “vasopressin escape”, characterized by low aquaporin-2 (AQP2) expression in the collecting duct despite high vasopressin secretion. We investigated this phenomenon in patients with the nephrotic syndrome. Patients and methods: We recruited 47 patients with proteinuric kidney disease who were distributed into the following four groups: 1) nephrotic syndrome with kidney dysfunction (n=10); 2) nephrotic syndrome with normal kidney function (n=16); 3) partial remission of nephrotic syndrome (n=10); and 4) minimal proteinuria (n=11). Nine healthy volunteers comprised a control group. Serum copeptin level (as a marker of vasopressin secretion) and urinary AQP2 were measured using ELISA. Results: Nephrotic syndrome was associated with a significant increase in serum copeptin levels compared with those in the other groups (all P<0.05). In patients with nephrotic syndrome and a partial remission of nephrotic syndrome combined, there was more than a ten-fold decrease in the median urinary AQP2 excretion (0.03 ng/mL) compared with healthy volunteers (0.41 ng/mL; P<0.001) and more than a five-fold decrease compared with patients with minimal proteinuria (0.21 ng/mL; P<0.05). Unlike copeptin levels, the median urinary AQP2 excretion in patients with minimal proteinuria also decreased but less significantly than in those with nephrotic syndrome. There was a negative correlation between the urinary AQP2 excretion and daily proteinuria (R=−0.41; P=0.005). Conclusion: Our clinical study was the first to demonstrate low AQP2 excretion in nephrotic syndrome that may indicate an escape from the vasopressin regulating effect. Keywords: nephrotic syndrome, aquaporin-2, copeptin, vasopressin escapehttps://www.dovepress.com/low-aquaporin-2-excretion-in-the-nephrotic-syndrome-an-escape-from-the-peer-reviewed-article-IJNRDnephrotic syndromeaquaporin-2copeptinvasopressin escape
spellingShingle Brovko M
Kozlovskaya L
Pulin A
Moiseev S
Sholomova V
Shchekochikhin D
Gognieva D
Milovanova L
Fomin V
Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
International Journal of Nephrology and Renovascular Disease
nephrotic syndrome
aquaporin-2
copeptin
vasopressin escape
title Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
title_full Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
title_fullStr Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
title_full_unstemmed Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
title_short Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
title_sort low aquaporin 2 excretion in the nephrotic syndrome an escape from the vasopressin regulating effect
topic nephrotic syndrome
aquaporin-2
copeptin
vasopressin escape
url https://www.dovepress.com/low-aquaporin-2-excretion-in-the-nephrotic-syndrome-an-escape-from-the-peer-reviewed-article-IJNRD
work_keys_str_mv AT brovkom lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT kozlovskayal lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT pulina lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT moiseevs lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT sholomovav lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT shchekochikhind lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT gognievad lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT milovanoval lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect
AT fominv lowaquaporin2excretioninthenephroticsyndromeanescapefromthevasopressinregulatingeffect